S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. - sprookjes - yvandenbroek - TriplyDB

S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species.

S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species.

http://www.wikidata.org/entity/Q33573630

about

Lysophospholipids and their receptors in the central nervous system Sphingosine 1-phosphate receptor agonists: a patent review (2010-2012)Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels.Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus.Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury.International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.Array data extractor (ADE): a LabVIEW program to extract and merge gene array data.Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxin Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient.Changes in the gene expression programs of renal mesangial cells during diabetic nephropathy Pleiotropic effects of pitavastatin Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration Sphingolipids in pulmonary fibrosis.Developing an in vitro screening assay platform for evaluation of antifibrotic drugs using precision-cut liver slices.Discovery, design and synthesis of a selective S1P(3) receptor allosteric agonist.Activation of transcription factor Nrf2 signalling by the sphingosine kinase inhibitor SKI-II is mediated by the formation of Keap1 dimers.Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix Knock out of S1P3 receptor signaling attenuates inflammation and fibrosis in bleomycin-induced lung injury mice model.Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde Insights into the pharmacological relevance of lysophospholipid receptors.Ablation of S1P3 receptor protects mouse soleus from age-related drop in muscle mass, force, and regenerative capacity.Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet-fed mice.Description of the sphingolipid content and subspecies in the diabetic cornea Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis.Sphingosine 1-phosphate receptor 2 (S1P2) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapy Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling Implication of sphingosin-1-phosphate in cardiovascular regulation.Sphingosine-1-phosphate acts as a key molecule in the direct mediation of renal fibrosis.The role of sphingolipid signalling in diabetes‑associated pathologies (Review).Sphingosine 1-phosphate in coagulation and inflammation.Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm.Cellular and molecular mechanisms of chronic inflammation-associated organ fibrosis.Sphingolipid regulation of tissue fibrosis Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy.The importance of sphingolipids and reactive oxygen species in cardiovascular development.Ebola virus: melatonin as a readily available treatment option.Unravelling the interplay of sphingolipids and TGF-β signaling in the human corneal stroma.

P2860

Q26859168-FA67984E-85B8-4399-BB4D-CFC33E3902C8 Q28288034-C7BA2CBA-60DC-48B6-8FE4-B286979100D9 Q28741063-67830023-2177-47AE-94BD-C5A4DCBDB7E1 Q30278904-87EACE4D-774E-44F0-B33B-9954BD30168F Q30404361-11485D06-DC5A-431F-903F-982EC1ECE4BE Q30416881-827B5760-A2BA-40C7-B1CE-E6C26A341FA4 Q30423883-EE10AC72-8A7A-4FBE-BB58-A56370886A06 Q30429523-52144283-D6B4-4A68-BCC8-D931ACA32B95 Q30704168-BFEA6242-5DEB-4585-80BE-61E439ADBF29 Q33631848-31665F50-D540-46B0-8045-49856F544D92 Q33753317-2FEA09DF-E9A5-45EE-B0EF-E30104B8C9AE Q33880223-F0624FAE-F552-4ED3-A4CA-5917A2571EB4 Q34290697-99453E13-B564-492D-94DF-D13CAC444CA6 Q34633506-4680485F-CA1A-4EDB-AFCA-0ED5E997F842 Q34678040-946D1DC2-F753-4345-90C5-FA276BE13E2A Q34921823-02271D8F-A52D-44C1-947A-2A5215EE9A22 Q34976113-CED317F8-56C3-479E-836C-26264E54D0E8 Q35019936-30FD83F3-40FD-4C18-9860-A0547E4D65BC Q35088548-6053C293-C67F-4389-B05B-5D041702E960 Q35132702-9C51A900-79A2-42EF-9B37-4BE8E8BAD1B9 Q35242288-4855FAE0-49E8-4401-A23F-A2DD3535A847 Q35264010-28D7B355-367E-424E-B071-F7F41763856E Q35853199-02A049A0-18FB-45A3-AE87-CDA8296A77AB Q36356594-975F907A-FF63-4523-ADD8-101A2A855E9B Q36410748-E3BDAA97-EFC8-439A-886C-D2C58A4071EC Q36608066-65B2B601-EED1-492B-BCC0-B33700B126F9 Q36710937-0763A5C9-CFEE-48FD-89B8-09BA4D44680B Q36799651-A12B20F7-4A97-4EB6-A320-E91B13F4CDFB Q36873593-84CC1CAB-714B-4AEC-B798-BA9DB10FC0CC Q36898368-DEC52562-75BF-40B0-ABE4-B8856184E14B Q37675523-61F09F32-0B47-41C7-890F-04A7D920F17A Q37711953-079DC667-F0F3-4B9F-B64B-DD69AB192385 Q37909176-A27F53D1-B293-4D24-8744-A3E419F880FE Q37929004-E3E48BF4-A2F9-4A1E-8435-54F04D603F65 Q38008371-DA4B51F7-CDA1-4AE8-BD28-2A61E5626B5B Q38026843-B4237D86-0DB1-402F-A8A6-04F1BAA3ABE0 Q38124049-8E29291A-2A52-4280-BBE6-1D86737E6269 Q38200125-0A3DD55A-D429-41FD-A2B8-FDA279FB7402 Q38328156-6DCD8E87-9DC2-445A-9729-43A9390DCFA8 Q38625631-E53F481F-A7E3-4386-956A-7C60F31970B0

P2860

S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species.

http://www.wikidata.org/entity/Q33573630

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

S1P3-mediated cardiac fibrosis ...... olves reactive oxygen species.

@ast

S1P3-mediated cardiac fibrosis ...... olves reactive oxygen species.

@en

S1P3-mediated cardiac fibrosis ...... olves reactive oxygen species.

@nl

type

label

S1P3-mediated cardiac fibrosis ...... olves reactive oxygen species.

@ast

S1P3-mediated cardiac fibrosis ...... olves reactive oxygen species.

@en

S1P3-mediated cardiac fibrosis ...... olves reactive oxygen species.

@nl

prefLabel

S1P3-mediated cardiac fibrosis ...... olves reactive oxygen species.

@ast

S1P3-mediated cardiac fibrosis ...... olves reactive oxygen species.

@en

S1P3-mediated cardiac fibrosis ...... olves reactive oxygen species.

@nl

P1433

Q33573630-A78E770C-A401-4294-99B7-71E7E9A907C7

P1476

Q33573630-7F6080F7-24CA-48B2-A10A-AB0209D507C7

P2093

Q33573630-0F7CF78C-D169-4D21-AEA5-281820F827F1

Q33573630-0FDFA1C0-34A4-4CED-B44B-A7406195A14A

Q33573630-19D66EA4-6395-423F-B97B-BB2CDCD9E48F

Q33573630-1D4D6056-E918-41A6-98A1-C783C6647278

Q33573630-21408DCF-FED7-4D2C-82C7-EE3397D95F3A

Q33573630-3B419992-20B8-4D96-879A-0684A60AA1AB

Q33573630-5030A330-B3D0-4308-B97F-197A8FCC458A

Q33573630-57CF6A7C-2E9F-48E0-A30E-BF4868ED13C1

Q33573630-63F73C85-DCAA-4264-8F05-D35CDBA4F149

Q33573630-6E63D0F3-03EA-481D-B8C0-E8E2C1E6829C

P2860

Q33573630-05683EA6-D51F-4A92-B944-7F32A7863DCA

Q33573630-07880494-AE1E-46C0-A56A-C0C99D48E20C

Q33573630-078EA9B0-977B-47A9-9258-9E93D8A8FD39

Q33573630-093B18F0-038B-42E7-94FB-72D10A90E7BA

Q33573630-0A9D6AD2-3575-469C-A4ED-93F23D03DA10

Q33573630-120BE41E-052B-46CC-8AE0-120B21C7B9FD

Q33573630-154A75E1-DB20-47F7-98AC-E99654CF9F08

Q33573630-2054C0E4-0043-4E63-BE5D-85AB3C3BA36D

Q33573630-28416C33-B974-48B1-AD5F-B4C98A33167E

Q33573630-2FAA51D7-B940-48F5-BABA-E8B8DE574899

P304

Q33573630-697C49DC-DA40-4071-9E2C-111CD4AACE10

P31

Q33573630-21D1008A-F4CC-40FE-B110-E39AAE95EACD

P356

Q33573630-D82A7773-71FE-4CD2-AC3B-89DEBC3F7C22

P433

Q33573630-65164690-DA50-49B1-ADFB-8F8556D9786E

P478

Q33573630-228D4DB1-20A0-4990-B02C-E0012B1CA4CA

P50

Q33573630-3C1334FE-545E-4276-BCBC-9E1254230B0E

Q33573630-7EE71AC4-CB35-4896-BAF4-1BA38631D098

Q33573630-8A69082F-5D99-4275-9E3A-D5C9881FABCE

P577

Q33573630-D259247D-3414-4B6F-9869-306495B5E688

P5875

Q33573630-44B8AB88-7406-4178-94DC-0EFA23A14B42

P698

Q33573630-23E455E9-574A-432D-941C-064AB4DAE8F1

P932

Q33573630-6948FFFA-42C0-40A4-9F86-ACEB1E29C65C

P356

P1433

Cardiovascular Research

P1476

S1P3-mediated cardiac fibrosis ...... olves reactive oxygen species.

@en

P2093

Fei Wang

http://www.w3.org/2001/XMLSchema#string

Ikuyo Ichi

http://www.w3.org/2001/XMLSchema#string

Jerold Chun

http://www.w3.org/2001/XMLSchema#string

Kaoru Hirano

http://www.w3.org/2001/XMLSchema#string

Kazuaki Yoshioka

http://www.w3.org/2001/XMLSchema#string

Keisuke Ohtani

http://www.w3.org/2001/XMLSchema#string

Kiyomi Mizugishi

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Satouchi

http://www.w3.org/2001/XMLSchema#string

Kunitoshi Mitumori

http://www.w3.org/2001/XMLSchema#string

Masayuki Takamura

http://www.w3.org/2001/XMLSchema#string

P2860

Essential role for sphingosine kinases in neural and vascular development

Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720

EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes

Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3

Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions

Requirement of Rac1 in the development of cardiac hypertrophy.

Functions of the multifaceted family of sphingosine kinases and some close relatives.

Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors.

Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling.

Lysophospholipid receptors: signaling and biology.

P304

484-493

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVP312

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26813256

http://www.w3.org/2001/XMLSchema#string

P698

19755413

http://www.w3.org/2001/XMLSchema#string

P932

2802201

http://www.w3.org/2001/XMLSchema#string